Navigation Links
BioNano Genomics Signs Two New Distributors For The Asia-Pacific Region And Announces First Irys System Placement In Korea To ChunLab
Date:7/16/2014

SAN DIEGO, SEOUL, South Korea and MELBOURNE, Australia, July 16, 2014 /PRNewswire/ -- BioNano Genomics announced today the selection of two new distributors, MDxK and Millennium Science, for the IrysTM System in the Asia-Pacific region. Based in Seoul, MDxK is one of the premier life science instrumentation distributors for Korea and has already sold the first system to ChunLab. Millennium Science, well known throughout Australia and New Zealand as a top genomics technology distributor, will market and support the Irys System in those two countries. The first institution to acquire the Irys System in this region, announced previously, was the Garvan Institute of Medical Research in Sydney. With the signing of these two new distributors, BioNano Genomics continues to expand the company's global footprint and provide access to the Irys System for genomics researchers to complete genomes and study structural variation.

"The Asia-Pacific region is in the midst of significant growth in genomics research which will demand integrated solutions to enable comprehensive exploration and comparison of genomes," said Todd Dickinson, Ph.D., vice president, Global Commercial Operations at BioNano Genomics. "We are thrilled to welcome MDxK and Millennium Science as key extensions to the BioNano team. Working with MDxK and Millennium Science, we will be able to serve all needs in these two Asia-Pacific regions for the Irys System, a single platform that provides an innovative, highly accurate genome map solution to rapidly identify structural variation, quickly assemble and complete de novo complex genomes, and perform comparative genomics studies."

Managing Director of Millennium Science, Mr. Bren Collinson, adds: "Our whole team is very excited about bringing the Irys System to our market as it will add another valuable dimension to the research that many of our genomics customers are currently performing. We have already received several enquiries about the system from the leading research facilities across Australia and New Zealand."

ChunLab, Inc. is the first next generation sequencing and bioinformatics service provider in South Korea to purchase the Irys System. The company plans to leverage the platform to advance its bioinformatics service and enable the finishing and scaffolding of highly complex genomes from bacteria to eukaryote at a more precise, efficient and cost-effective manner.

"A complete genome is essential in understanding the biological relevance of organisms. However, due to the inherent limitations of next generation sequencing such as GC bias and structural variation, de novo genome assembly is still a complex and time-consuming process. I am excited to purchase the Irys System for its ability to map any organism. I expect the system will help us more accurately and easily perform and validate assemblies," says Dr. Jongsik Chun, CEO of ChunLab. "More importantly the Irys system will give meaningful advancements to ChunLab's genomic research."

BioNano Genomics' Irys System creates a high-quality genome map to complete genome assembly and annotation and provides a single platform to perform comprehensive structural variation studies.  Genome maps built with the Irys System reveal the biologically and clinically significant order and orientation of functionally relevant components of complex genomes including genes, promoters, regulatory elements, the length and location of long regions of repeats as well as viral integration sites across the entire genome. Assembling such a comprehensive view of a genome has previously been a major hurdle because a significant portion of information about repetitive elements and structural variations are lost with next generation sequencing (NGS) methods.

About Irys System

The Irys System makes it possible to routinely and accurately detect genomic structural variation and to finish genome assemblies. The fully automated Irys benchtop instrument uses the IrysChipTM to uncoil and confine long DNA molecules in proprietary Nanochannel Arrays™ where they are uniformly linearized in a highly parallel display for high-resolution, single-molecule imaging. Irys does not employ DNA fragmentation or amplification, which are typical with next-generation sequencing. The result is sequence information over extremely long "reads" ranging from hundreds of kilobases to a megabase, where the sample's valuable structural information is preserved. Irys makes it possible for researchers to directly observe structural variants including replications, deletions, translocations and inversions.

About BioNano Genomics

Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company's platform provides researchers and clinicians the most comprehensive, organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. BioNano Genomics works with institutions in life science, translational research, molecular diagnostics and personalized medicine. The Company is supported by private investors and grant funding from genomics programs at federal agencies, including the NIH and NIST-ATP.

www.BioNanoGenomics.com

Notes: BioNano Genomics is a trademark of BioNano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.


'/>"/>
SOURCE BioNano Genomics
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. BioNano Genomics Announces the Adoption of Irys System by the Garvan Institute of Medical Research
2. BioNano Genomics Announces The Purchase Of The Irys System By The Chinese Academy Of Sciences And Tel Aviv University
3. BIT Group Partners with BioNano Genomics to Produce Revolutionary Genomics Platform
4. BioNano Genomics lanza Irys en Europa en ESHG 2013
5. BioNano Genomics f├╝hrt auf ESHG 2013 Irys in Europa ein
6. BioNano Genomics Launches Irys In Europe At ESHG 2013
7. Global Genomics and Proteomics Analytical Instruments Market 2014-2018
8. Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagens NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test
9. Tute Genomics Raises $1.5M for Cloud-based Genome Analytics & Machine-learning for Gene Discovery
10. Rubicon Genomics Reports Surge In 2013 Sales Of Its Nucleic Acid Library Prep Kits
11. Rubicon Genomics Expands Distribution in Europe and Asia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
(Date:2/23/2017)... Antonio, TX (PRWEB) , ... February 23, 2017 ... ... Drug Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the ... indicated for adults at home or in healthcare facilities during periods of rest. ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... The ... announce a new partnership with Compass Research . GGI's mission is to advance ... vaccine to a child in need in honor of each clinical trial volunteer. The ...
(Date:2/23/2017)... USA, and CARDIFF, UK (PRWEB) , ... February ... ... international society for optics and photonics , have been named Fellows of the ... significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and ...
Breaking Biology Technology:
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/8/2017)... Report Highlights The global biosurgery ... billion in 2016 at a compound annual growth rate ... Includes - An overview of the global market for ... from 2015 and 2016, and projections of compound annual ... market on the basis of product type, source, application, ...
(Date:2/6/2017)... 6, 2017 According to Acuity Market ... border authorities to continue to embrace biometric and ... 2143 Automated Border Control (ABC) eGates and 1436 ... more than 163 ports of entry across the ... achieving a combined CAGR of 37%. APC Kiosks ...
Breaking Biology News(10 mins):